Navigation Links
Keryx Biopharmaceuticals Announces Implementation of Strategic Restructuring Plan
Date:4/4/2008

forward-looking statements that involve a number of risks and uncertainties. For those statements, we claim the protection of the safe harbor for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995. Among the factors that could cause our actual results to differ materially are the following: our ability to successfully adjust our strategy and reduce our operating expenses in order to properly support the trials of our drug candidates; our ability to complete cost-effective clinical trials or meet anticipated the development timelines set forth above for the drug candidates in our pipeline, including Zerenex and KRX-0401; our ability to sell the $12 million of auction note securities in order to fund our operations; or other risk factors identified from time to time in our reports filed with the Securities and Exchange Commission. Any forward-looking statements set forth in this press release speak only as of the date of this press release. We do not intend to update any of these forward-looking statements to reflect events or circumstances that occur after the date hereof. This press release and prior releases are available at http://www.keryx.com. The information in our website is not incorporated by reference into this press release and is included as an inactive textual reference only.

KERYX CONTACT:

Lauren Fischer

Director - Investor Relations

Keryx Biopharmaceuticals, Inc.

Tel: 212.531.5965

E-mail: lfischer@keryx.com


'/>"/>
SOURCE Keryx Biopharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Keryx Biopharmaceuticals to Present at the Cowen and Company 28th Annual Health Care Conference
2. Keryx Biopharmaceuticals Announces that SUN-MICRO Phase 3 Clinical Trial Fails to Meet Primary Efficacy Endpoint
3. Keryx Biopharmaceuticals, Inc. Announces Fourth Quarter and Year-End 2007 Financial Results
4. Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Fourth Quarter and Year-End 2007 Financial Results on Monday, February 25, at 8:30 A.M. EST
5. Keryx Biopharmaceuticals Announces Additions to Management Team
6. Keryx Biopharmaceuticals Announces Upcoming Corporate Presentations
7. Keryx Biopharmaceuticals, Inc. Announces Third Quarter 2007 Financial Results
8. Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Third Quarter 2007 Financial Results on Thursday, October 25, at 8:30 A.M. EDT
9. Keryx Biopharmaceuticals, Inc. Enters into Licensing Agreement with Japan Tobacco and Torii Pharmaceutical for Development and Commercialization of Hyperphosphatemia Drug in Japan
10. Keryx Biopharmaceuticals, Inc. Announces Conference Call to Discuss Strategic Alliance
11. Keryx Biopharmaceuticals, Inc. Announces Appointment of Michael P. Tarnok to Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/1/2015)... Goldman Small Cap Research, a stock market research firm ... today that it has issued a new article on ... clinical stage biotechnology company focused on developing and preparing ... research article, along with disclosures and disclaimers, or to ... .  In the article on the ...
(Date:4/1/2015)... , April 1, 2015  EMD Serono, the ... Germany , announced today the appointment of ... Affairs, Neurology and Immunology. In this capacity, he will ... business development projects and collaborations for Rebif ® ... Neurology pipeline. Dr. Munschauer joins EMD ...
(Date:4/1/2015)... DUBLIN , Mar. 30, 2015 Research ... announced the addition of the "Blood Screening ... Rapid Test, Chemiluminescence Immunoassay, Next Generation Sequencing, Western ... Bank, Hospital) - Forecasts to 2019 " ... screening market is expected to reach $2.55 billion ...
(Date:4/1/2015)... - Canada,s Research-Based Pharmaceutical Companies (Rx&D) ... report on Cost Drivers of Public Drug Plans in ... report, the rates of change in drug costs have been ... percent in 2012/13 for a number of select public drug ... costs of medicines without considering their overall impact on the ...
Breaking Biology Technology:Flurry of Biotech Mergers and Acquisitions Bodes Well for PharmaCyte Biotech 2Flurry of Biotech Mergers and Acquisitions Bodes Well for PharmaCyte Biotech 3Flurry of Biotech Mergers and Acquisitions Bodes Well for PharmaCyte Biotech 4EMD Serono Appoints Frederick E. Munschauer M.D., FAAN to Vice President of Medical Affairs, Neurology and Immunology 2EMD Serono Appoints Frederick E. Munschauer M.D., FAAN to Vice President of Medical Affairs, Neurology and Immunology 3EMD Serono Appoints Frederick E. Munschauer M.D., FAAN to Vice President of Medical Affairs, Neurology and Immunology 4EMD Serono Appoints Frederick E. Munschauer M.D., FAAN to Vice President of Medical Affairs, Neurology and Immunology 5Global Blood Screening (Nucleic Acid Amplification Test, ELISA, Rapid Test, Chemiluminescence Immunoassay, Next Generation Sequencing, Western Blotting) Market 2015-2019 2Global Blood Screening (Nucleic Acid Amplification Test, ELISA, Rapid Test, Chemiluminescence Immunoassay, Next Generation Sequencing, Western Blotting) Market 2015-2019 3Rx&D responds to PMPRB report: overall impact of medicines must always be considered 2
... 6 Iomai Corporation,(Nasdaq: IOMI ) today announced ... officer, will present at the 10th Annual BIO,CEO & ... 12. Mr. Erck,s,presentation will begin at 2 p.m. Eastern ... Mr. Erck will give an update on corporate ...
... LARGO, Fla., Feb. 6 GeoPharma, Inc. (Nasdaq:,GORX) (the ... story,to as wide of an audience as possible it ... the company on its website at, http://www.GeoPharmainc.com under ... that it will be speaking publicly several times in,the ...
... Choices ( http://www.nhs.uk ), the,online ,front door, to ... measure your body mass index (BMI)., Based ... ) enables users to calculate in,seconds what their ... on maintaining or obtaining a healthy BMI. This ...
Cached Biology Technology:Iomai CEO to Speak at BIO CEO & Investor Forum on Feb. 12 2Recent Research Reports and Near-Term Corporate Events 2Recent Research Reports and Near-Term Corporate Events 3
(Date:3/16/2015)... Between 16 and 20 ... innovations in biometric identification at the CeBIT exhibition ...      (Photo: http://photos.prnewswire.com/prnh/20150316/735333 ) , ... at the forefront: the company,s all new BiometricGate ... Germany . BiometricGate is the first ...
(Date:3/12/2015)... 12, 2015 The mascots of the Atlantic ... part of Wake Forest Baptist Medical Center. They stopped ... 2015 ACC Men,s Basketball Tournament. Young patients enjoyed bonding ... getting their autographs. Brenner Children,s Hospital is ... the only children,s hospital in northwest North ...
(Date:3/12/2015)... , March 12, 2015 WHEN:Tuesday, March 17, ... here: http://bit.ly/1G7Os0L . SPEAKERS: , Frost & ... - http://photos.prnewswire.com/prnh/20150311/181111 Biometric companies ... compete in several different markets and industries. This ... witnessing an uptrend. Join Frost ...
Breaking Biology News(10 mins):DERMALOG Presents its Latest Biometric Innovations at the Hannover CeBIT Exhibition, 16 - 20 March 2015 2DERMALOG Presents its Latest Biometric Innovations at the Hannover CeBIT Exhibition, 16 - 20 March 2015 3Biometrics Key to Future Growth in Healthcare, Retail and Financial Markets 2Biometrics Key to Future Growth in Healthcare, Retail and Financial Markets 3
... critical point of failure in the microscopic transport system that ... study, published today in Nature Communications , explains how ... drugs and, as such, how this new discovery reveals how ... called ,railway, are tiny tubes, called microtubules, 1000 times thinner ...
... powerful gene-editing tool may be able to improve its ... in Nature Biotechnology , Massachusetts General Hospital (MGH) ... guide RNA (gRNA) component of the synthetic enzymes called ... of DNA mutations at sites other than the intended ...
... University of Hawaii Manoa (UHM) School of Ocean ... Laboratory, Lawrence Berkeley National Laboratory, and University of California ... deliver water and organics to the Earth and other ... come from comets, asteroids, and leftover debris from the ...
Cached Biology News:Cracks in the cellular transport system can be key to a new generation of cancer therapies 2Shortening guide RNA markedly improves specificity of CRISPR-Cas nucleases 2University of Hawaii scientists make a big splash 2University of Hawaii scientists make a big splash 3
... two color staining method for labeling DNA ... apoptotic cells by flow cytometry. The kit ... measuring apoptosis in cells including: positive and ... washing, reaction and rinsing buffers for processing ...
... APO-DIRECT Kit is a 2-color staining method ... DNA to detect apoptotic cells by flow ... reagents required for measuring apoptosis in cells ... assessing reagent performance; washing, reaction and rinsing ...
... cooling coil, Trans-Blot cell, provides ... high-intensity, and extended electrophoretic transfer ... Trans-Blot cell. Use of the ... to an external water recirculator, ...
... wide range of next-generation features into a ... standard for flexible laboratory solutions. It puts ... pipetting, dilution, dispensing, and integrations into ... and flexible as it is efficient and ...
Biology Products: